DOI QR코드

DOI QR Code

A Literature Review of Infection with ESKAPE Pathogens in Oral and Maxillofacial Region

  • Park, Sang-Yeap (Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University) ;
  • You, Jae-Seek (Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University) ;
  • Moon, Seong-Yong (Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University) ;
  • Oh, Ji-Su (Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University) ;
  • Choi, Hae-In (Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University) ;
  • Jung, Gyeo-Woon (Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University)
  • Received : 2021.07.19
  • Accepted : 2021.08.20
  • Published : 2021.09.30

Abstract

Odontogenic infection in the oral and maxillofacial regions caused by bacteria (mostly of oral origin) is one of the most common diseases encountered by dentists. Localized infection can easily be treated with incision and drainage followed by antibiotics. Emergence of multidrug resistant (MDR) bacteria called "Superbacteria" has become one of the serious problems in modern society, due to its small window of opportunity for treatment and high casualty. The acronym "ESKAPE", encompassing the common and serious MDR pathogens stand for Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. Literature search was performed in Medline, PubMed and Google Scholar ranging from 2012 to 2020. ESKAPE patient's infection period was longer than that of non-ESKAPE group, and the treatment method due to antibiotic resistance was also complicated. The purpose of this study is to investigate infection caused by ESKAPE pathogens in the oral and maxillofacial regions through literature review and to inform dental surgeons of the danger of ESKAPE pathogens and to suggest viable treatment options. Many studies worldwide reported infections associated with ESKAPE pathogens, but only limited number of studies targeted infection in oral and maxillofacial regions. Further research is required with more data on ESKAPE bacteria and their infection, especially in oral and maxillofacial regions.

Keywords

References

  1. Dahlen G. Microbiology and treatment of dental abscesses and periodontal-endodontic lesions. Periodontol 2000 2002;28:206-239. https://doi.org/10.1034/j.1600-0757.2002.280109.x
  2. Bertossi D, Barone A, Iurlaro A, et al. Odontogenic orofacial infections. J Craniofac Surg 2017;28:197-202. https://doi.org/10.1097/SCS.0000000000003250
  3. Kang SH, Kim MK. Antibiotic sensitivity and resistance of bacteria from odontogenic maxillofacial abscesses. J Korean Assoc Oral Maxillofac Surg 2019;45:324-331. https://doi.org/10.5125/jkaoms.2019.45.6.324
  4. Seppanen L, Lauhio A, Lindqvist C, Suuronen R, Rautemaa R. Analysis of systemic and local odontogenic infection complications requiring hospital care. J Infect 2008;57:116-122. https://doi.org/10.1016/j.jinf.2008.06.002
  5. Shweta, Prakash SK. Dental abscess: a microbiological review. Dent Res J (Isfahan) 2013;10:585-591.
  6. Nair PN. Pathogenesis of apical periodontitis and the causes of endodontic failures. Crit Rev Oral Biol Med 2004;15:348-381. https://doi.org/10.1177/154411130401500604
  7. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008;197:1079-1081.
  8. Stavropoulou E, Tsigalou C, Bezirtzoglou E. Spreading of antimicrobial resistance across clinical borders. Erciyes Med J 2019;41:238-243.
  9. Michiels JE, Van den Bergh B, Verstraeten N, Fauvart M, Michiels J. In vitro emergence of high persistence upon periodic aminoglycoside challenge in the ESKAPE pathogens. Antimicrob Agents Chemother 2016;60:4630-4637. https://doi.org/10.1128/AAC.00757-16
  10. Roca I, Akova M, Baquero F, et al. The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect 2015;6:22-29. https://doi.org/10.1016/j.nmni.2015.02.007
  11. Santajit S, Indrawattana N. Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int 2016;2016:2475067.
  12. Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PLoS One 2017;12:e0189621. https://doi.org/10.1371/journal.pone.0189621
  13. World Health Organization. Antimicrobial resistance: global report on surveillance. Geneva: World Health Organization; 2014.
  14. Ma YX, Wang CY, Li YY, et al. Considerations and caveats in combating ESKAPE pathogens against nosocomial infections. Adv Sci (Weinh) 2019;7:1901872.
  15. Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther 2013;11:297-308. https://doi.org/10.1586/eri.13.12
  16. NeVille-Swensen M, Clayton M. Outpatient management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infection. J Pediatr Health Care 2011;25:308-315. https://doi.org/10.1016/j.pedhc.2010.05.005
  17. Irani S. Orofacial bacterial infectious diseases: an update. J Int Soc Prev Community Dent 2017;7(Suppl 2):S61-S67.
  18. Murakami M, Nishi Y, Seto K, Kamashita Y, Nagaoka E. Dry mouth and denture plaque microflora in complete denture and palatal obturator prosthesis wearers. Gerodontology 2015;32:188-194. https://doi.org/10.1111/ger.12073
  19. Sakr A, Bregeon F, Mege JL, Rolain JM, Blin O. Staphylococcus aureus nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections. Front Microbiol 2018;9:2419. https://doi.org/10.3389/fmicb.2018.02419
  20. Reagan DR, Doebbeling BN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991;114:101-106.
  21. Kearney A, Kinnevey P, Shore A, et al. The oral cavity revealed as a significant reservoir of Staphylococcus aureus in an acute hospital by extensive patient, healthcare worker and environmental sampling. J Hosp Infect 2020;105:389-396. https://doi.org/10.1016/j.jhin.2020.03.004
  22. Serra R, Grande R, Butrico L, et al. Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus. Expert Rev Anti Infect Ther 2015;13:605-613. https://doi.org/10.1586/14787210.2015.1023291
  23. Avery CM, Ameerally P, Castling B, Swann RA. Infection of surgical wounds in the maxillofacial region and free flap donor sites with methicillin-resistant Staphylococcus aureus. Br J Oral Maxillofac Surg 2006;44:217-221. https://doi.org/10.1016/j.bjoms.2005.05.020
  24. Burduk PK, Skorek A, Stankiewicz C, Dalke K. Chronic, recurrent, progressive osteomyelitis of the maxilla caused by methicillinresistant Staphylococcus epidermidis: a therapeutic dilemma. J Oral Maxillofac Surg 2010;68:2012-2015.
  25. Tuzuner-Oncul AM, Ungor C, Dede U, Kisnisci RS. Methicillinresistant Staphylococcus aureus (MRSA) osteomyelitis of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107:e1-e4. https://doi.org/10.1016/j.tripleo.2009.03.002
  26. Li Z, Zhou Z, Li P, Zeng W, Qing H, Tang W. Retrospective study on multidrug-resistant bacterium infections after rigid internal fixation of mandibular fracture. J Oral Maxillofac Surg 2016;74:770-777. https://doi.org/10.1016/j.joms.2015.10.023
  27. Hwang JH, Lee JH, Hwang JH, et al. Comparison of arbekacin and vancomycin in treatment of chronic suppurative otitis media by methicillin resistant Staphylococcus aureus. J Korean Med Sci 2015;30:688-693. https://doi.org/10.3346/jkms.2015.30.6.688
  28. Lourtet-Hascoet J, Felice MP, Bicart-See A, Bouige A, Giordano G, Bonnet E. Species and antimicrobial susceptibility testing of coagulase-negative staphylococci in periprosthetic joint infections. Epidemiol Infect 2018;146:1771-1776. https://doi.org/10.1017/S0950268818001437
  29. Lee HJ, You JS. Postoperative infection caused by methicillinresistant coagulase-negative Staphylococci in the oral and maxillofacial region: a case report. J Oral Med Pain 2020;45:17-21. https://doi.org/10.14476/jomp.2020.45.1.17
  30. Gurusamy KS, Koti R, Toon CD, Wilson P, Davidson BR. Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non surgical wounds. Cochrane Database Syst Rev 2013;(11):CD010427.
  31. Batabyal B, Biswas S, Chakraborty S, Desai PD, De Sarkar N. Prevalence and drug sensitivity pattern of Staphylococcus aureus in post-operative surgical oral & maxillofacial infections. Int J Life Sci Pharma Res 2012;2:150-158.
  32. Garbino J, Inoubli S, Mossdorf E, et al. Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infection. AIDS 2008;22:701-705. https://doi.org/10.1097/QAD.0b013e3282f470ac
  33. Shu Kurizky P, Dos Santos Neto LL, Barbosa Aires R, Henrique da Mota LM, Martins Gomes C. Opportunistic tropical infections in immunosuppressed patients. Best Pract Res Clin Rheumatol 2020;34:101509.
  34. Park JJ, Seo YB, Lee J. Antimicrobial susceptibilities of Enterobacteriaceae in community-acquired urinary tract infections during a 5-year period: a single hospital study in Korea. Infect Chemother 2017;49:184-193. https://doi.org/10.3947/ic.2017.49.3.184
  35. Barlean MC, Balcos C, Bobu LI, et al. Microbiological evaluation of surgical site infections in the Clinic of Oral and Maxillofacial Surgery of the Sf.Spiridon Clinical Hospital in Iasi, Romania. Rev Chim 2019;70:4077-4082. https://doi.org/10.37358/RC.19.11.7705
  36. Oh DH, Kim YC, Kim EJ, et al. Multidrug-resistant Acinetobacter baumannii infection in lung transplant recipients: risk factors and prognosis. Infect Dis (Lond) 2019;51:493-501. https://doi.org/10.1080/23744235.2018.1556400
  37. Bilal M, Janan A, Irfanullah MA. Occurrence of methicillin resistant staphylococcus aureus (MRSA) in patients requiring reconstructive surgery. Pak J Surg 2014;30:301-305.
  38. Amin D, Satishchandran S, Drew S, Abramowicz S. Diagnosis and treatment of lip infections. J Oral Maxillofac Surg 2021;79:133-140. https://doi.org/10.1016/j.joms.2020.06.025
  39. Valderrama-Beltran S, Gualtero S, Alvarez-Moreno C, et al. Risk factors associated with methicillin-resistant Staphylococcus aureus skin and soft tissue infections in hospitalized patients in Colombia. Int J Infect Dis 2019;87:60-66. https://doi.org/10.1016/j.ijid.2019.07.007
  40. Brito TP, Hazboun IM, Fernandes FL, et al. Deep neck abscesses: study of 101 cases. Braz J Otorhinolaryngol 2017;83:341-348. https://doi.org/10.1016/j.bjorl.2016.04.004
  41. Shah A, Ramola V, Nautiyal V. Aerobic microbiology and culture sensitivity of head and neck space infection of odontogenic origin. Natl J Maxillofac Surg 2016;7:56-61. https://doi.org/10.4103/0975-5950.196126
  42. Gudiol C, Ayats J, Camoez M, et al. Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes. PLoS One 2013;8:e74734. https://doi.org/10.1371/journal.pone.0074734
  43. Candevir Ulu A, Kurtaran B, Inal AS, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs. Med Sci Monit 2015;21:219-224. https://doi.org/10.12659/MSM.892516
  44. Maslikowska JA, Walker SA, Elligsen M, et al. Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs. J Hosp Infect 2016;92:33-41. https://doi.org/10.1016/j.jhin.2015.10.001
  45. Xiao J, Zhang C, Ye S. Acinetobacter baumannii meningitis in children: a case series and literature review. Infection 2019;47:643-649. https://doi.org/10.1007/s15010-018-1234-1
  46. Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 2005;11:22-29. https://doi.org/10.3201/eid1101.040001
  47. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008;46:1254-1263. https://doi.org/10.1086/529198
  48. Park SY, Choo JW, Kwon SH, et al. Risk factors for mortality in patients with Acinetobacter baumannii bacteremia. Infect Chemother 2013;45:325-330. https://doi.org/10.3947/ic.2013.45.3.325
  49. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1-12. https://doi.org/10.1086/595011
  50. Paramythiotou E, Lucet JC, Timsit JF, et al. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis 2004;38:670-677. https://doi.org/10.1086/381550
  51. Moradigaravand D, Palm M, Farewell A, Mustonen V, Warringer J, Parts L. Prediction of antibiotic resistance in Escherichia coli from large-scale pan-genome data. PLoS Comput Biol 2018;14:e1006258.
  52. Zhen X, Lundborg CS, Sun X, Hu X, Dong H. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrob Resist Infect Control 2019;8:137. https://doi.org/10.1186/s13756-019-0590-7
  53. Giulieri SG, Tong SYC, Williamson DA. Using genomics to understand meticillin- and vancomycin-resistant Staphylococcus aureus infections. Microb Genom 2020;6:e000324.
  54. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999;341:1906-1912. https://doi.org/10.1056/NEJM199912163412507
  55. Takai S, Kuriyama T, Yanagisawa M, Nakagawa K, Karasawa T. Incidence and bacteriology of bacteremia associated with various oral and maxillofacial surgical procedures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:292-298. https://doi.org/10.1016/j.tripleo.2004.10.022
  56. Jang SJ, Lee YG, Ahn Y, Leem DH, Baek JA, Shin HK. A clinicostastical study of oral and maxillofacial infected patients for the last 5 years. J Korean Assoc Oral Maxillofac Surg 2006;32:401-409.
  57. Veronez B, de Matos FP, Monnazzi MS, Sverzut AT, Sverzut CE, Trivellato AE. Maxillofacial infection. A retrospective evaluation of eight years. Braz J Oral Sci 2014;13:98-103.
  58. Marturano JE, Lowery TJ. ESKAPE pathogens in bloodstream infections are associated with higher cost and mortality but can be predicted using diagnoses upon admission. Open Forum Infect Dis 2019;6:ofz503. https://doi.org/10.1093/ofid/ofz503
  59. Fishman N. Antimicrobial stewardship. Am J Med 2006;119(6 Suppl 1):S53-S61; discussion S62-S70. https://doi.org/10.1016/j.amjmed.2006.04.003